Barclays analyst Hassan Al-Wakeel downgraded Sonova (SONVY) to Underweight from Equal Weight with a price target of CHF 225, down from CHF 275. The firm believes the stock’s valuation remains elevated relative to peers despite downside risks to the fiscal year guidance.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SONVY: